Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration.

All engineered bioartificial structures developed for tissue regeneration require oxygen and nutrients to establish proper physiological functions. Aiming to improve vascularization during dermal regeneration, we combined the use of a bioartificial collagen scaffold and a defined human mesenchymal cell (MC) line. This cell line, termed V54/2, exhibits typical morphologic and immunohistochemical characteristics of MC. V54/2 cells seeded in the scaffold were able to survive, proliferate, and secrete significant amounts of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) during 2 weeks in vitro. To induce dermal regeneration, scaffolds with or without cells were transplanted in a nude mice full skin defect model. After 2 weeks of transplantation, scaffolds seeded with V54/2 cells showed more vascularization during the dermal regeneration process than controls, and the presence of human cells in the regenerating tissue was detected by immunohistochemistry. To confirm if local presence of angiogenic growth factors is sufficient to induce neovascularization, scaffolds were loaded with VEGF and bFGF and used to induce dermal regeneration in vivo. Results showed that scaffolds supplemented with growth factors were significantly more vascularized than control scaffolds (scaffolds without growth factors). The present work suggests that combined use of MC and bioartificial scaffolds induces therapeutic angiogenesis during the scaffold-based dermal regeneration process.

[1]  H. Hodges,et al.  Making Stem Cell Lines Suitable for Transplantation , 2007, Cell transplantation.

[2]  Martin Ehrbar,et al.  Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Ulrich Kneser,et al.  Gene transfer strategies in tissue engineering , 2007, Journal of cellular and molecular medicine.

[4]  Y. Tabata,et al.  Collagen–poly glycolic acid hybrid matrix with basic fibroblast growth factor accelerated angiogenesis and granulation tissue formation in diabetic mice , 2006, The Journal of dermatology.

[5]  Yasuhiko Tabata,et al.  Collagenous matrices as release carriers of exogenous growth factors. , 2004, Biomaterials.

[6]  W. Jiang,et al.  The role of vascular endothelial growth inhibitor in wound healing , 2007, International wound journal.

[7]  Gerhard Ehninger,et al.  Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.

[8]  J Bonadio,et al.  Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. , 2000, Advanced drug delivery reviews.

[9]  Jos Malda,et al.  The roles of hypoxia in the in vitro engineering of tissues. , 2007, Tissue engineering.

[10]  H. Navsaria,et al.  In vitro characterization of an artificial dermal scaffold. , 2001, Tissue engineering.

[11]  A. Keçi̇k,et al.  Osteocutaneous Flap Prefabrication Based on the Principle of Vascular Induction: An Experimental and Clinical Study , 2000, Plastic and reconstructive surgery.

[12]  W. Lindenmaier,et al.  [Influence of vascular endothelial growth factor gene modification on skin substitute grafted on nude mice]. , 2005, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns.

[13]  C. Croce,et al.  Association of SV40 with human tumors , 2002, Oncogene.

[14]  M. Pierschbacher,et al.  Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. , 1997, Biomaterials.

[15]  F. Haselton,et al.  Seeding of Corneal Wounds by Epithelial Cell Transfer from Micropatterned PDMS Contact Lenses , 2005, Cell transplantation.

[16]  Kerry A Landman,et al.  Cell Proliferation and Oxygen Diffusion in a Vascularising Scaffold , 2007, Bulletin of mathematical biology.

[17]  D. Heimbach,et al.  Artificial Dermis for Major Burns: A Multi‐Center Randomized Clinical Trial , 1988, Annals of surgery.

[18]  Alexander M Seifalian,et al.  The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. , 2005, Biomaterials.

[19]  W. Freed,et al.  An Immortalized Rat Ventral Mesencephalic Cell Line, RTC4, Is Protective in a Rodent Model of Stroke , 2007, Cell transplantation.

[20]  E. Middelkoop,et al.  Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[21]  S. Kinston,et al.  GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line. , 2002, Experimental hematology.

[22]  R. Kurzrock,et al.  Vascular Endothelial Growth Factor and Its Relationship to Inflammatory Mediators , 2007, Clinical Cancer Research.

[23]  Anthony Atala,et al.  Principals of neovascularization for tissue engineering. , 2002, Molecular aspects of medicine.

[24]  A. Condurache,et al.  Ex vivo method to visualize and quantify vascular networks in native and tissue engineered skin , 2009, Langenbeck's Archives of Surgery.

[25]  M. Tomic-Canic,et al.  Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. , 2003, Surgical technology international.

[26]  A. Condurache,et al.  VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. , 2007, Langenbeck's archives of surgery (Print).

[27]  Ulrich Kneser,et al.  Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. , 2007, Tissue engineering.

[28]  Chueh Shangkai,et al.  Transplantation of allogeneic chondrocytes cultured in fibroin sponge and stirring chamber to promote cartilage regeneration. , 2007, Tissue engineering.

[29]  Ki Suk Park,et al.  Repair of diaphyseal bone defects with calcitriol-loaded PLGA scaffolds and marrow stromal cells. , 2007, Tissue engineering.

[30]  D. Hutmacher,et al.  Tissue engineered prefabricated vascularized flaps , 2007, Head and Neck.

[31]  H. Machens,et al.  Bioartificial Skin , 2000, Cells Tissues Organs.

[32]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[33]  H. Augustin,et al.  Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.

[34]  D. Chung,et al.  Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis , 2007, Clinical Cancer Research.

[35]  Jie Li,et al.  Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix , 2003, Microscopy research and technique.

[36]  N. Moiemen,et al.  Reconstructive Surgery with Integra Dermal Regeneration Template: Histologic Study, Clinical Evaluation, and Current Practice , 2006, Plastic and reconstructive surgery.

[37]  D. Hollander,et al.  Autologous keratinocytes cultured on benzylester hyaluronic acid membranes in the treatment of chronic full-thickness ulcers. , 1999, Journal of wound care.

[38]  Andrés Hurtado,et al.  Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. , 2006, Biomaterials.

[39]  J. Pipas,et al.  SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation , 2005, Oncogene.

[40]  Christopher Breuer,et al.  Artificial blood vessel: the Holy Grail of peripheral vascular surgery. , 2005, Journal of vascular surgery.

[41]  D. Wisser,et al.  Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma. , 2003, Burns : journal of the International Society for Burn Injuries.